logo
Select company
Select metric
-7784.52%Free Cash Flow Margin
VS
Market
2
Sector
6
Industry
11
History
5
$ 4.03Close
$ 1.96 - $ 4.21 52-Week Range
Ticker Information

Ticker

VTGN

Company Name

VISTAGEN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VISTAGEN THERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VTGN - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -50.29M-7784.52%$ 646K
3/31/2025$ -42.29M-8701.23%$ 486K
12/31/2024$ -39.36M-5637.09%$ 698.3K
9/30/2024$ -33.65M-3842.81%$ 875.7K
6/30/2024$ -28.89M-2977.55%$ 970.4K
3/31/2024$ -25.87M-2431.77%$ 1.06M
12/31/2023$ -26.12M-2506.08%$ 1.04M
9/30/2023$ -31.5M-3886.37%$ 810.5K
6/30/2023$ -41.67M0%$ -359.7K
3/31/2023$ -49.93M0%$ -227.3K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VISTAGEN THERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at -2622.93%.
  • Over the past 5 years, VISTAGEN THERAPEUTICS INC's average FCF % has been -3603.21%.
  • The median FCF % for VISTAGEN THERAPEUTICS INC during this period was -2800.24%
  • VISTAGEN THERAPEUTICS INC reached its highest FCF % over the past 5 years at -1098.99%.
  • The lowest FCF % recorded by VISTAGEN THERAPEUTICS INC in the same timeframe -8701.23%

VISTAGEN THERAPEUTICS INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
RNXT : RENOVORX INC -1559.06%BTAI : BIOXCEL THERAPEUTICS INC -6424.54%ABVC : ABVC BIOPHARMA INC -448.8%COYA : COYA THERAPEUTICS INC -3890.1%AVTX : AVALO THERAPEUTICS INC -10752.38%ZTEK : ZENTEK LTD -419.2%ENTX : ENTERA BIO LTD -4033.73%INO : INOVIO PHARMACEUTICALS INC -52004.59%RPTX : REPARE THERAPEUTICS INC -41335.2%LEXX : LEXARIA BIOSCIENCE CORP -1585.78%

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for VISTAGEN THERAPEUTICS INC is calculated as follows: FCF [ $ -8.76M ] / Revenues [ $ 334K ]
(=) FCF % [ -2622.93% ]

VTGN - Free Cash Flow Margin, Last 5 years

-8701.23%

Minimum

Mar 31, 2025

-1098.99%

Maximum

Jun 30, 2021

-3603.21%

Average

-2800.24%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.87% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.87%
median7.4%
std19.48%